Robert CHU worked for IBM in Europe and the US for more than 15 years, serving in key technical and management. In June of 2007, Robert CHU joined IMS Health France and served as the General Manager in 2011. He then moved to China in 2013 to run the Asia Pacific and China operations for IMS Health. Robert was subsequently promoted in 2015 to Senior Vice President, Global Technology Solutions, responsible for the management of a $800 million software business for the healthcare industry globally. In 2017, he founded Embleema, the platform that is revolutionising clinical trials and the sharing of health data.